<?xml version="1.0" encoding="UTF-8"?>
<p>To obtain a source of RVFV and SBV-specific VHHs with potential neutralizing activity for the respective viruses, llamas were inoculated with the live-attenuated RVFV vaccine strain Clone 13, RVFV virus-like particles (VLPs) or SBV NL-F6 (
 <xref ref-type="fig" rid="fig1">Figure 1A</xref>). All inoculated animals responded well with virus-specific neutralizing antibodies in serum above a 50% neutralizing titer of 500 (
 <xref ref-type="fig" rid="fig1">Figure 1B</xref>; 
 <xref rid="bib70" ref-type="bibr">Wichgers Schreur et al., 2017</xref>; 
 <xref rid="bib49" ref-type="bibr">Loeffen et al., 2012</xref>). The B-cell-derived VHH phagemid libraries contained &gt;10
 <sup>7</sup> unique clones per animal.
</p>
